| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. (OVID) has 5 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. OVID is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.44M | $4.02M | - | |
| Dir | 217.6K | $609.2K | - | |
| Dir | 17.6K | $49.2K | - | |
| Dir | 8.8K | $24.6K | - | |
| Other | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 | Levin Jeremy M | CEO | Buy | 75,000 | $2.00 | $150,000.00 | +1.6% | |
| Aug 14, 2018 | Williams Douglas E | Director | Buy | 5,000 | $6.49 | $32,441.50 | New | |
| Aug 14, 2018 | Bernstein Karen | Director | Buy | 10,000 | $6.23 | $62,300.00 | New | |
| Aug 25, 2017 | Levin Jeremy M | CEO | Buy | 15,334 | $7.15 | $109,638.10 | +0.3% |